At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 42 enrolled
Drug / intervention
Promiseb Topical Cream +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Double Blind, Placebo-Controlled, Pilot Study to Estimate the Efficacy and Tolerability of Twice Daily Promiseb Topical Cream in Pediatric Subjects With Cradle Cap (Seborrheic Dermatitis)
In Brief
A Phase 4 clinical trial evaluating Promiseb Topical Cream and Bland emollient for Cradle Cap and Infantile Seborrheic Dermatitis. Completed, enrolled 42 participants across 4 sites.
Detailed Summary
The purpose of this study is to evaluate the efficacy and safety of Promiseb Topical Cream in cradle cap.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCradle Cap, Infantile Seborrheic Dermatitis
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartMar 2010
First PostedOct 2010
Primary CompletionJun 2011
TodayJul 2026
First PostedOct 5, 2010
Enrollment StartMar 1, 2010
Primary CompletionJun 1, 2011
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 15.7 years ago
Interventions
Promiseb Topical Creamdevice
topical non steroidal cream, twice daily
Bland emollientother
Eucerin cream twice daily